Cell-Based Arrays for Personalized Chemotherapy Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for predicting the success of combination chemotherapeutic treatments in cancer patients are limited due to the rarity of cancer stem cells, which are difficult to isolate and test, leading to variability in treatment outcomes across patients.
Innovation Solution
Development of cell-based arrays with non-fouling layers and timed-release polymer layers that allow for the targeted delivery of multiple agents to cancer cells, enabling the analysis of drug combinations on a small number of cells, thereby facilitating personalized chemotherapy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If traditional methods are used to test chemotherapeutic drugs, then sufficient cells are available for testing, but the rarity of cancer stem cells makes it difficult to screen potential agents
Solution Approach 1:
The invention divides the testing process into two stages: first, expand cancer stem cells in 3D spheroid cultures to generate sufficient cell quantities; second, distribute these expanded cells across multiple array positions to test various drug combinations. This segmentation resolves the contradiction by separating cell expansion from drug screening.
Solution Approach 2:
The invention transitions from traditional 2D monolayer cell cultures to 3D spheroid cultures, enabling exponential cell expansion in the third dimension. This dimensional change allows sufficient cancer stem cells to be generated for comprehensive drug combination screening while maintaining cell rarity constraints.
2Measurement precision
If more cells are used for drug screening, then statistical significance is improved, but the limitation of having very few available cells on which to test drug combinations persists
Solution Approach 1:
The invention performs preliminary cell expansion by culturing cancer stem cells in 3D spheroid formats before drug screening. This preliminary action generates a large pool of cells that can then be distributed across multiple array positions, ensuring sufficient cell numbers for statistically significant drug response measurements.
Solution Approach 2:
The 3D spheroid culture system serves multiple functions: it expands cell numbers, maintains cancer stem cell properties, and provides a platform for high-throughput drug combination screening. This multi-functionality resolves the contradiction by achieving both statistical significance and cell quantity constraints simultaneously.
3Reliability
If combinations of chemotherapeutic drugs are used to target multiple critical pathways, then treatment outcome is enhanced, but oncologists lack the tools necessary to predict the success of various combination treatments
Solution Approach 1:
The invention introduces cell-based arrays as an intermediary tool between drug combination selection and treatment outcome prediction. These arrays experimentally test drug combinations on patient-derived cancer stem cells, providing empirical data that predicts treatment success without requiring complex theoretical models.
Solution Approach 2:
The invention changes the parameter of cell culture dimensionality from 2D to 3D, which fundamentally alters cell behavior and drug response characteristics. This parameter change enables more accurate prediction of in vivo treatment outcomes while simplifying the prediction process through direct experimental measurement rather than complex modeling.
4Measurement precision
If rare cancer stem cells are targeted for therapy, then treatment precision is improved, but the rarity of these cells makes it difficult to isolate and test
Solution Approach 1:
The invention uses 3D spheroid culture as a dimensional transition that simultaneously enriches for cancer stem cells and expands their numbers. This dimensional change makes rare cell isolation easier while maintaining high precision in target cell identification.
Solution Approach 2:
The invention merges cell expansion and target enrichment into a single 3D spheroid culture process. This merging resolves the contradiction by achieving both precise cancer stem cell identification and sufficient cell quantities for testing without requiring separate complex isolation procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The arrays enable efficient screening of drug combinations on rare cancer stem cells, reducing the need for large cell quantities and providing insights into personalized treatment regimens, thereby improving treatment outcomes.
Implementation Method 1
a non-fouling layer disposed in a first area of the array, where cells do not substantially adhere to the non-fouling layer
Implementation Method 2
the timed-release polymer has the characteristic of releasing the agent to the cell or cells adhered to the cell binding site
Data Source
AI summary
Embodiments of the present disclosure provide for arrays, systems, and methods analyzing cells, methods of making arrays, and the like.